Table 2.
Patient population demographics and clinical characteristics
| Frequency (%) | ||
|---|---|---|
| Sex | M | 136 (69.0%) |
| Etiology of liver disease | Viral | 72 (36.5%) |
| Other etiologies | 63 (32.3%) | |
| ALD | 40 (20.3%) | |
| MASLD | 14 (7,2%) | |
|
PSC Autoimmune |
5 (2.5%) 1 (0.5%) |
|
| HCC treatment performed before imaging follow-up | 105 (53.3%) | |
| RFTA | 44 (41.9%) | |
| Surgical resection | 23 (21.9%) | |
| TACE | 22 (20.9%) | |
| MWA | 14 (13.3%) | |
| SIRT | 2 (1.9%) | |
| LI-RADS | LR < = 3 | 134 (68.7%) |
| LR 4 | 21 (10.7%) | |
| LR 5 | 40 (20.5%) | |
| Average (SD) | ||
| Age | 63.8 (9.0) |
ALD: alcohol-associated liver disease; MASLD: metabolic dysfunction-associated liver disease; MWA: microwave ablation; PSC: primary sclerosing cholangitis; RFTA: radiofrequency thermoablation; SIRT: selective internal radiation therapy; TACE: transarterial chemoembolization